University of Oregon
Eugene, Oregon, 97403, United States
Location status: Recruiting
Location contact
Damien M Callahan, Ph.D.
CONTACT
Damien M Callahan, Ph.D.
PRINCIPAL_INVESTIGATOR
NCT Number: NCT05926219
This study is investigating changes to the proteins in skeletal muscle that contribute to reduced muscle size and muscle function that occurs with aging.
Interested in participating?
Request Info18 year–80 year
All sexes
Interventional
Not applicable
Eugene, Oregon, 97403, United States
Location status: Recruiting
Damien M Callahan, Ph.D.
CONTACT
Damien M Callahan, Ph.D.
PRINCIPAL_INVESTIGATOR
Age-related muscle atrophy and contractile dysfunction have been well described at the cellular level, but the molecular mechanisms that contribute to this dysfunction are poorly understood. Improved understanding of these mechanisms is critically important for the improvement of physical rehabilitation in older adults at risk for mobility impairment and physical disability. Our studies will pursue pre-clinical evidence that post translational modification of specific proteins in skeletal muscle lead to an "aging phenotype" in skeletal muscle that may unlock new strategies for improving physical function in older adults with physical frailty.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Volunteers will perform knee extension exercise of the dominant limb while seated in a chair designed for exercise of the knee extensor muscle group. The chair will be equipped with a lever arm, aligned with the axis of rotation of the knee and fixed to the distal shank, 2 centimeters proximal to the ankle joint. The lever arm will be instrumented to provide resistance and measure velocity. The volunteers will perform 3-5 maximum voluntary contractions (MVC) to determine peak torque. Once established, volunteers will rest for 5 minutes before initiating the fatigue protocol, whereby they will perform repeated MVC of the dominant limb against resistance equal to or less than 50% of MVC until range of motion cannot be maintained. Because the goal of this exercise is to uniformly fatigue the quadriceps muscle group, this exercise will be performed continuously. It is expected to take between 1 and 3 minutes to achieve the desired level of fatigue.
Time frame: One week after the participant undergoes the biopsies.
Muscle tissue is immediately frozen after biopsy. Liquid chromatography and high resolution mass spectrometry will be used to do a full analysis of the phosphorylation sites on MyBP-C isolated from the biopsied muscle tissue.
Time frame: Within three weeks of the intervention and biopsies.
Ex vivo assessment of Force (mN) will be performed on muscle fibers and bundles isolated from fatigued and non-fatigued muscle biopsies.
Time frame: Within three weeks of the intervention and biopsies.
Ex vivo assessment of Tension (kPa) will be performed on muscle fibers and bundles isolated from fatigued and non-fatigued muscle biopsies.
Time frame: Within three weeks of the intervention and biopsies.
Ex vivo assessment of Velocity (Lo/s) will be performed on muscle fibers and bundles isolated from fatigued and non-fatigued muscle biopsies.
Time frame: Within three weeks of the intervention and biopsies.
Ex vivo assessment of Power (w/L) will be performed on muscle fibers and bundles isolated from fatigued and non-fatigued muscle biopsies.
Contact information is provided by the study sponsor or research team.
Damien M Callahan, Ph.D.
CONTACT
Karen Wiedenfeld Needham, BS
CONTACT
University of Oregon
Other
Skeletal Muscle Myosin Binding Protein C in Fatigue and Aging
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07597850
Aging, Asthenia
Taipei, Taiwan
View Trial DetailsNCT06689618
Aging, Atrophy
Columbia, Missouri, United States
View Trial DetailsNCT07726498
Aging, Asthenia
Leicester, United Kingdom
View Trial DetailsNCT07689487
Aging, Atrophy
Antalya, Turkey (Türkiye)
View Trial Details